SA Pathology to cease the use of numbing creams

SA Pathology will cease the provision and application of numbing creams (EMLA) in its collection centres by the end of 2025.

In Australia, the use of topical anaesthetic numbing creams is regulated by the Therapeutic Goods Administration and in South Australia under the Controlled Substance Act 1984 (the Act). SA Pathology's decision to cease the use of numbing creams in collection centres ensures compliance with these regulations across our network.

SA Pathology anticipates patients will benefit from a reduction in wait times, particularly in the paediatric collection centres, as numbing creams can take a minimum of 60 minutes to be fully effective.

Patients may choose to apply numbing cream prior to attending a collection centre. SA Pathology recommends they discuss the correct use and application of these products with their GP or pharmacist to ensure potential side-effects and contraindications with other medications are considered.

Research shows that distraction is the most effective tool in reducing anxiety during needle procedures, which is were the Buzzy and Smileyscope distraction devices can help. They are available at select collection centres across the SA Pathology network, and locations can be found on the SA Pathology website.

Please note: EMLA cream will still be available at the Women's and Children's Hospital collection centre, Monday to Friday, upon request. This ensures the cream is applied by our nursing staff who are fully qualified in medical administration.